RVMD News

Lost Money on Erasca, Inc. (ERAS)? Join Class Action Before August 10, 2026 - Contact Levi & Korsinsky

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

Securities Fraud Class Action Filed Against Erasca, Inc. (ERAS) – Levi & Korsinsky Reminds Investors of August 10, 2026

Contact Levi & Korsinsky by August 10, 2026 to Join Class Action Against Erasca, Inc. (ERAS)

Lost Money on Erasca, Inc. (ERAS)? Join Class Action Before August 10, 2026 – Contact Levi & Korsinsky

Lost Money on Erasca, Inc. (ERAS)? Join Class Action Before August 10, 2026 - Contact Levi & Korsinsky

ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Did You Lose Money on Erasca, Inc. (ERAS)? Levi & Korsinsky Urges Investors to Act Before August 10, 2026

Erasca, Inc. (ERAS) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before August 10, 2026

August 10, 2026 Deadline Approaching: Join Class Action Against Erasca, Inc. (ERAS) - Contact Levi & Korsinsky